NXNN | Nexeon MedSystems Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2017	2016
Revenue	3.3 Million	1.49 Million
Cost of Revenue	3.61 Million	676.05 Thousand
Gross Profit	-316.69 Thousand	818.83 Thousand
Operating Expenses	5.94 Million	1.45 Million
Selling, General and Administrative Expenses	3 Million	693.6 Thousand
Research and Development Expenses	2.94 Million	759.5 Thousand
Other Expenses	-	-
Cost and Expenses	9.56 Million	2.12 Million
Operating Income	-6.26 Million	-634.27 Thousand
Interest Expense	113.96 Thousand	13.73 Thousand
Income Tax Expense	-2037.00	-19.04 Thousand
Earnings before Tax	-2.17 Million	-802.46 Thousand
Net Income	-2.17 Million	-802.46 Thousand
Earnings Per Share Basic	-1.23	-0.59
Earnings Per Share Diluted	-1.23	-0.59
Weighted Average Shares Outstanding	1.77 Million	1.36 Million
Weighted Average Shares Outstanding (Diluted)	1.77 Million	1.36 Million
Gross Margin	-0.10	0.55
EBIT Margin	-1.50	0.00
Profit Margin	-0.66	-0.54
EBITDA	-765.96 Thousand	-151.8 Thousand
Earnings Before Tax Margin	-1.90	-0.42

Breakdown	2017 FY	2016 FY
Revenue	3.3 Million	1.49 Million
Cost of Revenue	3.61 Million	676.05 Thousand
Gross Profit	-316.69 Thousand	818.83 Thousand
Operating Expenses	5.94 Million	1.45 Million
Selling, General and Administrative Expenses	-	-
Research and Development Expenses	-	-
Other Expenses	-	-
Cost and Expenses	9.56 Million	2.12 Million
Operating Income	-6.26 Million	-634.27 Thousand
Interest Expense	113.96 Thousand	13.73 Thousand
Income Tax Expense	-2037.00	-19.04 Thousand
Earnings before Tax	-2.17 Million	-802.46 Thousand
Net Income	-2.17 Million	-802.46 Thousand
Earnings Per Share Basic	-	-
Earnings Per Share Diluted	-	-
Weighted Average Shares Outstanding	1.77 Million	1.36 Million
Weighted Average Shares Outstanding (Diluted)	1.77 Million	1.36 Million
Gross Margin	-0.10	0.55
EBIT Margin	-	-
Profit Margin	-0.66	-0.54
EBITDA	-	-
Earnings Before Tax Margin	-1.90	-0.42